All Psoriasis articles
-
Formulary decision guideAmgevita® ▼ (adalimumab biosimilar)
This formulary discussion guide was developed from content provided by Amgen Ltd in a format developed by Guidelines in Practice .
-
Pharmacist focus
Psoriasis: the role of the practice pharmacist
Ruari O’Connell and Anna Prescott describe the role of the clinical practice-based pharmacist in managing patients with psoriasis
-
Implementing guidelines
Psoriasis: PCDS treatment pathway provides practical advice for GPs
Drs Angela Goyal and Kash Bhatti provide an overview of the PCDS primary care treatment pathway for psoriasis and discuss the importance of lifestyle advice and skin-directed treatment
-
Test and reflect
PCDS pathway on psoriasis treatment in primary care
This CPD activity consists of 5 multiple-choice questions (MCQs) designed to test your knowledge on the treatment of psoriasis—you will then be prompted to reflect on your learning.
-
News
BAD updates guideline on biologic therapy for psoriasis
The British Association of Dermatologists (BAD) has updated its guideline on biologic therapy for psoriasis . The guideline, which is accredited by NICE, provides evidence-based recommendations on the use of biologic therapies (including adalimumab, etanercept, infliximab, ixekizumab, secukinumab, and ustekinumab) in adults, children, and young people for the treatment of ...
-
News
PCDS publishes guideline on psoriasis
The Primary Care Dermatology Society has published a primary care treatment pathway for psoriasis
-
Good practice initiative
Auditing psoriasis care: an example from Redhill, Surrey
Dr Kenneth Lim answers questions on how an audit of psoriasis care at a GP practice in Surrey improved outcomes for patients
-
Top tips
Top tips: psoriasis
Dr Rebecca Mawson shares some key points for managing psoriasis in primary care and how to screen for psoriatic arthritis
-
Implementing guidelines
Tailoring psoriasis treatments is key to symptom control
Dr Riadh Dawood presents an overview of current treatment options for psoriasis and some sources of help for patients and practitioners for this challenging condition
-
Implementing guidelines
A holistic approach is essential at all stages of psoriasis management
Dr Natasha Smeaton explains how the NICE guideline aims to improve quality of life for patients with psoriasis and prompt identification of psoriatic arthritis
-
Implementing guidelines
Coordinated care will improve outcomes in patients with psoriasis
Dr Iain Henderson discusses the SIGN recommendations on diagnosis and treatment of patients with psoriasis and psoriatic arthritis and when individuals should be referred
-
Implementing guidelines
Quality of life should be considered when treating psoriasis
Dr Riadh Dawood describes how psoriasis can be managed with a range of treatments including topical, ultraviolet, systemic, and biological therapies
-
Implementing guidelines
A range of therapies are available for the treatment of psoriasis
Dr Alison Roberts outlines the different types of psoriasis and reviews the topical, systemic, and biological interventions that can be used ...
-
Personal view
Infliximab is approved by NICE for adult psoriasis
Dr Alison Roberts welcomes the guidance from NICE and a new treatment for patients with the severe form of the disease
-
Personal view
NICE issues guidance on prescription of adalimumab
Dr Louise Warburton discusses how authorisation of this effective medication will revolutionise treatment for psoriatic arthritis
-
Implementing guidelines
Two new treatments will benefit psoriasis patients
NICE technology appraisal lists those patients who will be eligible for new drug therapies, as Dr Alison Roberts explains
-
Hot topic
Selecting effective treatment for guttate psoriasis
The choice of treatment for guttate psoriasis is hampered by the lack of controlled trials for the available therapies, as Drs Caroline Owen and Robert Chalmers report
-
Implementing guidelines
Psoriasis guidelines improve patient care
Dr Tom Poyner explains how guidelines on the treatment of psoriasis could promote shared care to the benefit of patients
